# Evaluation of the Efficacy and Safety of Suppressive Therapy With DALBAVANCINE in Device Infections

> **NCT06089044** · — · COMPLETED · sponsor: **Tourcoing Hospital** · enrollment: 15 (actual)

## Conditions studied

- Prosthesis-related Infections

## Interventions

- **DRUG:** Dalbavancin Injection

## Key facts

- **NCT ID:** NCT06089044
- **Lead sponsor:** Tourcoing Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-01
- **Primary completion:** 2022-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2023-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06089044

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06089044, "Evaluation of the Efficacy and Safety of Suppressive Therapy With DALBAVANCINE in Device Infections". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT06089044. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*